IP Verse

Elkington And Fife patent opposition analysis

The comprehensive analysis of Elkington And Fife opposition landscape, with a particular emphasis on intellectual property (IP) dynamics.

Latest patent oppositions filed by Elkington And Fife

Stay updated with the latest patent oppositions filed by Elkington And Fife

Patent NumberTitleApplicantOpposition DateOpposition Company
EP4582070
Absorbent Article With Anti-Leakage Transversal BarrierONTEX BVAug 19, 2026THE PROCTER & GAMBLE
EP4249069
Aqueous Formulation Comprising 1-(4-{[4-(Dimethylamino)Piperidin-1-Yl]Carbonyl}Phenyl)-3-[4-(4,6-Dimorpholin-4-Yl-1,3,5-Triazin-2-Yl)Phenyl]UreaPFIZER INC.Aug 16, 2026ELKINGTON AND FIFE
EP4197530
Ribociclib TabletNOVARTIS AGAug 11, 2026GENERICS UK
EP3500575
Crystalline Form Of (S)-7-(1-Acryloylpiperidin-4-Yl)-2-(4-Phenoxyphenyl)-4,5,6,7-Tetra-Hydropyrazolo[1,5-A]Pyrimidine-3-Carboxamide, Preparation, And Uses ThereofBEONE MEDICINES I GMBHAug 3, 2026SANDOZ
EP3856182
Compositions And Methods For Treating Disorders Ameliorated By Muscarnic Receptor ActivationKARUNA THERAPEUTICS, INC.Jul 30, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD
EP3834824
Method Of Treating Cancer Using Selective Estrogen Receptor ModulatorsDUKE UNIVERSITYJul 14, 2026SANDOZ
EP3908266
Liquid CompositionsKENVUE BRANDS LLCJul 14, 2026THE PROCTER & GAMBLE
EP3932167
Implement Mounted Sensors Sensing Surface/Furrow Characteristics And ControlDEERE & COMPANYJul 7, 2026AGCO
EP4021507
Methods Of Treating Heart Failure With Reduced Ejection Fraction With DapagliflozinASTRAZENECA ABJul 1, 2026GENERICS UK
EP3860594
Biphenyl Sulfonamide Compounds For The Treatment Of Type Iv Collagen DiseasesTRAVERE THERAPEUTICS, INC.Jun 30, 2026TEVA PHARMACEUTICAL INDUSTRIES LTD

Top clients of Elkington And Fife

Top companies who are the clients of Elkington And Fife

CompanyTotal
GENERICS UK127
ELKINGTON AND FIFE92
NESTLE42
SANDOZ41
THE PROCTER & GAMBLE39
SOCIT DES PRODUITS NESTL33
TEVA PHARMACEUTICAL INDUSTRIES LTD25
COOKE24
TEVA UK LIMITED17
POLPHARMA15